Braxia Scientific Corp.
BRAXFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$28328
P/E Ratio—
52W High$0.00128
52W Low$0.0001
Braxia Scientific Corp. (BRAXF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BRAXF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2024Report Date: Feb 29, 2024EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q1 FY2024
FY ends December
Report Date
Feb 29, 2024
After Market Close
BRAXF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2025 | Mar 17, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Feb 26, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Nov 27, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Aug 29, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 1, 2024 | — | — | — | — | — | — |
| — Q1 FY2024 | Feb 29, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2023 | Nov 29, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2023 | Aug 29, 2023 | — | -$0.00 | — | $0.00B | — | — |
Q1 FY2025
Mar 17, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Feb 26, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 27, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 29, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 1, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Feb 29, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Nov 29, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2023
Aug 29, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2024 | $0.00 | — | $0.00 | 0 |
| Q1 FY2024 | $0.00 | — | $0.00 | 0 |
| Q4 FY2023 | $0.00 | — | $0.00 | 0 |
| Q3 FY2023 | $0.00 | — | $0.00 | 0 |
| Q2 FY2023 | $0.00 | — | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2024 | Feb 29, 2024 | — | $0.01 | $0.01 | -2.11% |
| — Q4 FY2023 | Nov 29, 2023 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2023 | Aug 29, 2023 | — | $0.01 | $0.01 | +3.61% |
| — Q1 FY2023 | Mar 1, 2023 | — | $0.05 | $0.05 | +0.00% |
| — Q1 FY2023 | Feb 27, 2023 | — | $0.05 | $0.04 | -7.90% |
| — Q4 FY2022 | Nov 29, 2022 | — | $0.03 | $0.03 | -3.75% |
| — Q3 FY2022 | Aug 29, 2022 | — | $0.06 | $0.06 | -1.29% |
Q1 FY2024-2.11%
Report Date
Feb 29, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2023+0.00%
Report Date
Nov 29, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2023+3.61%
Report Date
Aug 29, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2023+0.00%
Report Date
Mar 1, 2023
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q1 FY2023-7.90%
Report Date
Feb 27, 2023
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.04
Q4 FY2022-3.75%
Report Date
Nov 29, 2022
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q3 FY2022-1.29%
Report Date
Aug 29, 2022
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.06
Beat Rate0 / 7 quarters
Largest Move-7.90% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BRAXF ends December
Braxia Scientific Corp. (BRAXF) most recently reported earnings on February 29, 2024 for Q1 FY2024, posting EPS of $-0.00 (in line with the analyst consensus of —). The next BRAXF earnings date is expected around September 1, 2026.
Each quarter, investors track BRAXF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BRAXF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BRAXF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BRAXF earnings · 4 questionsBraxia Scientific Corp.'s next earnings report is expected around September 1, 2026. BRAXF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BRAXF historically reports after market close (AMC).
BRAXF earnings datewhen is BRAXF earningsBRAXF next earnings datewhen does BRAXF report earningsBRAXF earnings calendar
▸ Source: FMP · Braxia Scientific Corp. SEC filings · US GAAP · Braxia Scientific Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026